For decades, the daf-2 mutant has been our North Star for longevity research. But let’s be honest: we didn't actually create a better worm. We built a metabolic deserter. That ten-fold lifespan extension we celebrate in C. elegans isn't a victory for vitality; it’s a graceful surrender. By suppressing insulin/IGF-1 signaling, these worms sink into a kind of functional poverty. They move less, they reproduce less, and they’ve basically opted out of the biological pressures that define their existence. They survive longer because they’ve stopped participating in life.

Is that really the goal? If we translate these "successes" to humans, we won't be engineering a future of 150-year-old polymaths. We’ll be engineering biological stasis. The problem is an obsession with chronological persistence over metabolic flux. We’re treating the cell like a museum piece—something to be preserved behind glass—rather than an engine that requires high turnover to maintain its structural integrity. When we dampen the acetylation rheostat to lower metabolic noise, we might protect the genome, but we're letting the proteomic architecture petrify.

We have to stop measuring how long an organism lasts and start measuring how much life it can handle. We need metrics for homeorhetic resilience—the capacity to maintain high-energy states without triggering the inflammatory collapse of the NLRP3 inflammasome.

I'm looking for collaborators who are tired of staring at survival curves and want to map functional velocity. If our interventions require us to become "less" of ourselves to live longer, then we haven't cured aging. We've just subsidized a more expensive form of atrophy. Should we really be funding models that achieve longevity through developmental arrest? Or is it time to admit that a 10x lifespan extension in a "broken" organism is just a scientific dead end?